Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: A mechanistic study

Food and Chemical Toxicology

Volumn 71, Issue , 2014, Pages 183-196

  Arya, Aditya ^a   Jamil Al Obaidi, Mazen M ^b   Shahid, Nayiar ^a   Bin Noordin, Mohamed Ibrahim ^a   Looi, Chung Yeng ^a   Wong, Won Fen ^a   Khaing, Si Lay ^a   Mustafa, Mohd Rais ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UiTM Malaysia   (Malaysia)

Author keywords

Diabetes mellitus; Quercetin; Quinic acid; Streptozotocin; Synergistic effect

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ALBUMIN; C PEPTIDE; CATALASE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; QUERCETIN; QUINIC ACID; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ANTIOXIDANT; ENZYME; MALONALDEHYDE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVITY; GLOMERULUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HYPERGLYCEMIA; HYPERLIPIDEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY DISEASE; LIPOPROTEIN BLOOD LEVEL; LIVER DISEASE; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PANCREAS DISEASE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE DEGENERATION; TOXICITY TESTING; UPREGULATION; ADULT; DIABETES MELLITUS; DRUG DOSE COMPARISON; FEMALE; KIDNEY; LIVER; LIVER HISTOLOGY; PANCREAS; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTIOXIDANTS; DRUG SYNERGISM; ENZYMES; KIDNEY; LIVER; MALE; MALONDIALDEHYDE; PANCREAS; QUERCETIN; QUINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 84903982380     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.06.010     Document Type: Article

References (67)

1. Aguirre L., Arias N., Macarulla M.T., Gracia A., Portillo M.P. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceut. J. 2011, 4:189-198.
2. Arya A., Achoui M., Cheah S.-C., Abdelwahab S.I., Narrima P., Mohan S., Mustafa M.R., Mohd M.A. Inhibitory role in human tumor cells. Chloroform fraction of Centratherum anthelminticum (L.) seed inhibits tumor necrosis factor alpha and exhibits pleotropic bioactivities:Evidence-Based Complementary and Alternative Medicine. 2012, 10.1155/2012/627256.
3. Arya A., Looi C.Y., Cheah S.C., Mustafa M.R.B., Mohd M.A. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats. Journal of Ethnopharmacol. 2012, 144(1):22-32.
4. Arya A., Cheah S.C., Looi C.Y., Taha H., Mustafa M.R., Mohd M.A. The methanolic fraction of Centratherum anthelminticum seed downregulates pro-inflammatory cytokines, oxidative stress, and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats. Food Chem. Toxicol. 2012, 50(11):4209-4220.
5. Balakumar P., Aror M.K., Ganti S.S., Reddy J., Singh M. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol. Res. 2009, 60(1):24-32.
6. +-ATPase expression and oxidative stress. Am. J. Pharmacol. Toxicol. 2014, 9(1):84-95.
7. Brezar V., Carel J.C., Boitard C., Mallone R. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. Endocr. Rev. 2011, 32(5):623-669.
8. Bureau G., Longpré F., Martinoli M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J. Neurosci. Res. 2008, 86(2):403-410.
9. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 2004, 24(5):816-823.
10. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol. Res. 2005, 51(2):117-123.
11. Cotter M., Cameron N. Effect of the NAD (P) H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 2003, 73(14):1813-1824.
12. De Silva D.D., Rapior S., Hyde K.D., Bahkali A.H. Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Divers. 2012, 56(1):1-29.
13. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., González-Gallego J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 2005, 135(10):2299-2304.
14. Elgawish A., Glomb M., Friedlander M., Monnier V.M. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J. Biol. Chem. 1996, 271(22):12964-12971.
15. Eslami F., Sharifi A.M. Role of Bax protein and caspase-3 at high glucose-induced apoptosis in human embryonic kidney (HEK) 293 cells. Zahedan J. Res. Med. Sci. 2012, 15(5):25-29.
16. Farah A., Donangelo C.M. Phenolic compounds in coffee. Braz. J. Med. Biol. Res. 2006, 18(1):23-36.
17. Fernandez-Alvarez J., Barbera A., Nadal B., Barcelo-Batllori S., Piquer S., Claret M., Gomis R. Stable and functional regeneration of pancreatic beta-cell population in STZ-rats treated with tungstate. Diabetologia 2004, 47(3):470-477.
18. Gorzalczany S., Sülsen V., Redko F., Vescina C., Muschietti L., Martino V., Acevedo C. Choleretic and antispasmodic effects of Lippia integrifolia aqueous extract. Rev. Bras. Farmacogn. 2008, 18(1):16-20.
19. Gurzov E.N., Eizirik D.L. Bcl-2 proteins in diabetes: mitochondrial pathways of b-cell death and dysfunction. Trends Cell Biol. 2011, 21(7):424-429.
20. Hii C.S., Howell S.L. Effects of epicatechin on rat islets of Langerhans. Diabetes 1984, 33(3):291-296.
21. Inal M., Akgün A., Kahraman A. Radioprotective effects of exogenous glutathione against whole-body g-ray irradiation: age-and gender-related changes in malondialdehyde levels, superoxide dismutase and catalase activities in rat liver. Methods Finds Exp. Clin. Pharmacol. 2002, 24(4):209-212.
22. Kandasamy N., Ashokkumar N. Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium-induced experimental diabetic nephrotoxic rats. Biomed. Prev. Nutr. 2012, 2(4):246-251.
23. Kandhare A.D., Raygude K.S., Shiva Kumar V., Rajmane A.R., Visnagri A., Ghule A.E., Bodhankar S.L. Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats. Biomed. Aging Pathol. 2012, 2(4):173-186.
24. Ke Y.D., Delerue F., Gladbach A., Götz J., Ittner L.M. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE 2009, 4(11):e7917.
25. Laughton M.J., Evans P.J., Moroney M.A., Hoult J., Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 1991, 42(9):1673-1681.
26. Lee S.Y., Moon E., Kim S.Y., Lee K.R. Quinic acid derivatives from Pimpinella brachycarpa exert anti-neuroinflammatory activity in lipopolysaccharide-induced microglia. Bioorg. Med. Chem. Lett. 2013, 23(7):2140-2144.
27. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990, 186:464-478.
28. Li H., Telemaque S., Miller R.E., Marshi J.D. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 2005, 54:540-545.
29. Lian H.D., Ren B., Gao X.W. Effects of minocycline on expression of bcl-2, bax in early retinal neuropathy of diabetes in rats. Int. J. Ophthal. Pathol. 2011, 4(2):162.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
31. Machha A., Achike F.I., Mustafa A.M., Mustafa M.R. Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 2007, 16(4):442-447.
32. Mahesh T., Menon V.P. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother. Res. 2004, 18(2):123-127.
33. Matsubara T., Abe H., Arai H., Nagai K., Mima A., Kanamori H., Doi T. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Invest. 2006, 86(4):357-368.
34. Middleton E. Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 1998, 439:175-182.
35. Mitra S., Gopumadhavan S., Muralidhar T., Anturlikar S., Sujatha M. Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 1996, 54(1):41-46.
36. Mohamed A.K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler R., Nawroth P.P. The role of oxidative stress and NF- kappa B activation in late diabetic complications. BioFactors 1999, 10(2):157-167.
37. Motshakeri M., Ebrahimi M., Goh Y.M., Othman H.H., Hair-Bejo M., Mohamed S. Effects of brown seaweed (Sargassum polycystum) extracts on kidney, liver, and pancreas of type 2 diabetic rat model. Evid. Based Compl. Alternat. Med. 2014, 2014:379407.
38. Nayak S.S., Pattabiraman T. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin. Chim. Acta 1981, 109(3):267-274.
39. Nuraliev I., Avezov G. The efficacy of quercetin in alloxan diabetes. Eksp. Klin. Farmakol. 1991, 55(1):42-44.
40. OECD, 1998. OECD Guidelines for Testing of Chemicals, OECD Publishing.
41. Ong K.W., Hsu A., Song L., Huang D., Tan B.K.H. Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2011, 133(2):598-607.
42. Palmer J.P., Fleming G.A., Greenbaum C.J., Herold K.C., Jansa L.D., Kolb H., Lachin J.M., Polonsky K.S., Pozzilli P., Skyler J.S., Steffes M.W. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004, 53(1):250-264.
43. Pero R.W., Lund H., Leanderson T. Antioxidant metabolism induced by quinic acid. Increased urinary excretion of tryptophan and nicotinamide. Phytother. Res. 2009, 23(3):335-346.
44. Pooja V.S., Samanta K. Hypoglycemic activity of methanolic extract of Tectona grandis linn. Root in alloxan induced diabetic rats. J. Appl. Pharm. Sci. 2011, 1(4):106-109.
45. Prince P., Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 2006, 20(2):96-102.
46. Raghavan V.A., Garber A.J. Postprandial hyperglycemia. Type 2 Diabetes Mellitus, An Evidence Based Approach to Practical Management 2008, 97-114. Humana Press, New York. M.N. Feinglos, M.A. Bethel (Eds.).
47. Rice-Evans C. Flavonoid antioxidants. Curr. Med. Chem. 2001, 8(7):797-807.
48. Rifaai R.A., El-Tahawy N.F., Saber E.A., Ahmed R. Effect of quercetin on the endocrine pancreas of the experimentally induced diabetes in male albino rats: a histological and immunohistochemical study. J. Diabetes Metab. 2012, 3(3):182.
49. Roat R., Rao V., Doliba N.M., Matschinsky F.M., Tobias J.W., Garcia E., Ahima R.S., Imai Y. Alterations of pancreatic islet structure, metabolism and gene expression in diet-induced obese C57BL/6J mice. PLoS ONE 2014, 9(2):e86815.
50. Rusznyak S., Szent-Györgyi A. Vitamin P: flavonols as vitamins. Nature 1936, 138:27.
51. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414(6865):799-806.
52. Sanders R.A., Rauscher F.M., Watkins J.B. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 2001, 15(3):143-149.
53. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 1979, 21(1):104-107.
54. Singh S.N., Vats P., Suri S., Shyam R., Kumria M., Ranganathan S., Sridharan K. Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats. J. Ethnopharmacol. 2001, 76(3):269-277.
55. Sohn E., Kim J., Kim C.S., Kim Y.S., Jang D.S., Kim J.S. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats. Biochem. Biophys. Res. Commun. 2010, 391(1):733-738.
56. Sohn E.J., Kim C.S., Kim Y.S., Jung D.H., Jang D.S., Lee Y.M., Kim J.S. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci. 2007, 80(5):468-475.
57. Taha H., Arya A., Paydar M., Looi C.Y., Wong W.F., Vasudeva M.C., Hadi A.H.A. Upregulation of insulin secretion and downregulation of pro-inflammatory cytokines, oxidative stress and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats by Pseuduvaria monticola bark extract. Food Chem. Toxicol. 2014, 66:295-306.
58. Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 135(3):357-364.
59. Vishwakarma S.L., Sonawane R.D., Rajani M., Goyal R.K. Evaluation of effect of aqueous extract of Enicostemma littorale Blume in streptozotocin-induced type 1 diabetic rats. Indian J. Exp. Biol. 2010, 48(1):26-30.
60. Wang J., Pan Y., Zhang Q.Y., Wang X.N., Kong L.D. Quercetin protects against cadmium-induced renal uric acid transport system alteration and lipid metabolism disorder in rats. J. Evid. Based Complem. Altern. Med. 2012, 2012:548430.
61. World Diabetes Foundation, 2010. <> (05.03.11]. http://www.worlddiabetes.
62. WHO, 2006. Diabetes Programme. <> (15.10.07). http://www.who.Int/diabetes/en/2006.
63. WHO, 2008. Traditional medicine. <> (26.05.09). http://www.who.int/mediacentre/factsheets/fs134/en/2008.
64. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998, 50(1):21-34.
65. Yokoyama A., Yokoyama A., Sakakibara H., Yokoyama A., Sakakibara H., Crozier A., Kumazawa S. Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats. Free Radic. Res. 2009, 43(10):913-921.
66. Yousef M.I., Omar S.A., El-Guendi M.I., Abdelmegid L.A. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem. Toxicol. 2010, 48(11):3246-3261.
67. Zhou J.Y., Zhou S.W., Zhang K.B. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol. Pharm. Bull. 2008, 31(6):1169-1176.